Vaccination against Monkeypox is open in pre-exposure to all exposed audiences, in particular to MSM and/or TDS. The fact remains that contact cases of infected persons must also continue to be informed of the importance of being vaccinated post-exposure and this as soon as possible. Research on this post-exposure vaccination is currently underway. AIDES is a partner as a member of the scientific council of this research coordinated by Professor Jade Ghosn of Bichat Hospital in Paris. The objective is to assess the effectiveness of post-exposure vaccination. Open in four centers in Paris (Bichat, Saint-Antoine, Pitié-Salpêtrière, Hôtel Dieu) and in the University Hospitals of Rennes, Bordeaux and Nantes, this research consists of a visit on D0 accompanied by vaccination, two follow-up visits at 7 and 14 days and a final visit at 28 days with booster vaccination. Participation is compensated 100 euros (in total). If you are a contact case yourself or if you know a contact case person who should benefit from a post-exposure vaccination, it is suggested that you write to Dr Liem Binh Luong (liem.luong “@” aphp.fr) , who is piloting the study and who will be able to organize rapid care, with a proposal for inclusion in the study, in one of the centers concerned.
Monkeypox : vaccination des cas contacts
The flu epidemic is still increasing, with an impact on hospitalizations and deaths, but at a slower...
The Ministry of Health calls on citizens to complete the stimulus dose of the Corona virus
NHL: Martin St-Louis shows his exasperation after the loss of CH, 3 to 2 against the Senators
Shiffrin no longer gives interviews, but does not start in the Super-G - Goggia - Winter Sports
Psychomotor Therapy and Research - Number 2022/3 - N° 187 - Formation and transformation of psychomo...
Inauguration of the Latin American School of Medicine 'Dr. Salvador Allende' by President Nicolás Ma...
Lopetegui insults El Haddadi and the player is close to leaving Sevilla
Optimizing Blood Circulation: Tips for Health and Longevity